_id
69104ee5ccc777a4e85d5368
Ticker
CINGW
Name
Cingulate Inc. Warrants
Exchange
NASDAQ
Address
1901 West 47th Place, Kansas City, KS, United States, 66205
Country
USA
Sector
Industry
Currency
USD
Website
https://www.cingulate.com
Description
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Last Close
0.0628
Volume
14019
Current Price
0.06
Change
-0.0081
Last Updated
2026-01-02T11:25:45.141Z
Image
data:image/webp;base64,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
Ipo Date
2021-12-08T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
106782
Gross Profit
-106782
Operating Expenses
5889053
Operating Income
-5995835
Interest Expense
573058000
Pretax Income
-7341062
Net Income
-7341062
Eps
-1.3516449201153482
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-7234278
Operating Margin
-
Total Other Income Expense Net
-1345227
Cash
6118710
Short Term Investments
-
Receivables
19041
Inventories
-
Total Current Assets
7433310
Property Plant Equipment
3085582
Total Assets
10518892
Payables
866245
Short Term Debt
3415888
Long Term Debt
-
Total Liabilities
7045206
Equity
3473686
Bs_currency_symbol
USD
Depreciation
106782
Change In Working Capital
1099643
Cash From Operations
-4244354
Capital Expenditures
4
Cash From Investing
-
Cash From Financing
1462881
Net Change In Cash
-2781473
Cf_currency_symbol
USD
PE
-
PB
0.09381169167276489
ROE
-211.33349416153334
ROA
-69.78930860778873
FCF
-4244358
Fcf Percent
-
Piotroski FScore
1
Health Score
28
Deep Value Investing Score
3
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
1
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
106782
Quarters > 0 > income Statement > gross Profit
-106782
Quarters > 0 > income Statement > operating Expenses
5889053
Quarters > 0 > income Statement > operating Income
-5995835
Quarters > 0 > income Statement > interest Expense
573058000
Quarters > 0 > income Statement > pretax Income
-7341062
Quarters > 0 > income Statement > net Income
-7341062
Quarters > 0 > income Statement > eps
-1.3516449201153482
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5431206
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7234278
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1345227
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6118710
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
19041
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
7433310
Quarters > 0 > balance Sheet > property Plant Equipment
3085582
Quarters > 0 > balance Sheet > total Assets
10518892
Quarters > 0 > balance Sheet > payables
866245
Quarters > 0 > balance Sheet > short Term Debt
3415888
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7045206
Quarters > 0 > balance Sheet > equity
3473686
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7341062
Quarters > 0 > cash Flow > depreciation
106782
Quarters > 0 > cash Flow > change In Working Capital
1099643
Quarters > 0 > cash Flow > cash From Operations
-4244354
Quarters > 0 > cash Flow > capital Expenditures
4
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1462881
Quarters > 0 > cash Flow > net Change In Cash
-2781473
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-1.3516449201153482
Quarters > 0 > ratios > PB
0.09381169167276489
Quarters > 0 > ratios > ROE
-211.33349416153334
Quarters > 0 > ratios > ROA
-69.78930860778873
Quarters > 0 > ratios > FCF
-4244358
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
146989
Quarters > 1 > income Statement > gross Profit
-146989
Quarters > 1 > income Statement > operating Expenses
4502985
Quarters > 1 > income Statement > operating Income
-4649974
Quarters > 1 > income Statement > interest Expense
138761000
Quarters > 1 > income Statement > pretax Income
-4788735
Quarters > 1 > income Statement > net Income
-4788735
Quarters > 1 > income Statement > eps
-1.0909609713256627
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4389465
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4641745
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-138761
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8900183
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
19585
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10222668
Quarters > 1 > balance Sheet > property Plant Equipment
3245540
Quarters > 1 > balance Sheet > total Assets
13468208
Quarters > 1 > balance Sheet > payables
872853
Quarters > 1 > balance Sheet > short Term Debt
5358108
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7956334
Quarters > 1 > balance Sheet > equity
5511874
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4788735
Quarters > 1 > cash Flow > depreciation
146989
Quarters > 1 > cash Flow > change In Working Capital
-426743
Quarters > 1 > cash Flow > cash From Operations
-4795257
Quarters > 1 > cash Flow > capital Expenditures
5923
Quarters > 1 > cash Flow > cash From Investing
-5925
Quarters > 1 > cash Flow > cash From Financing
4182399
Quarters > 1 > cash Flow > net Change In Cash
-618783
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.0909609713256627
Quarters > 1 > ratios > PB
0.04778191591462359
Quarters > 1 > ratios > ROE
-86.8803423300315
Quarters > 1 > ratios > ROA
-35.55584380639206
Quarters > 1 > ratios > FCF
-4801180
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
165291
Quarters > 2 > income Statement > gross Profit
-165291
Quarters > 2 > income Statement > operating Expenses
3540744
Quarters > 2 > income Statement > operating Income
-3706035
Quarters > 2 > income Statement > interest Expense
96656000
Quarters > 2 > income Statement > pretax Income
-3802691
Quarters > 2 > income Statement > net Income
-3802691
Quarters > 2 > income Statement > eps
-1.0427207488675978
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3646893
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3637404
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-96656
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
9518966
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
41573
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
10504972
Quarters > 2 > balance Sheet > property Plant Equipment
1964616
Quarters > 2 > balance Sheet > total Assets
12469588
Quarters > 2 > balance Sheet > payables
855150
Quarters > 2 > balance Sheet > short Term Debt
4158080
Quarters > 2 > balance Sheet > long Term Debt
923698
Quarters > 2 > balance Sheet > total Liabilities
6538768
Quarters > 2 > balance Sheet > equity
5930820
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3802691
Quarters > 2 > cash Flow > depreciation
165291
Quarters > 2 > cash Flow > change In Working Capital
-1413177
Quarters > 2 > cash Flow > cash From Operations
-4608282
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1915927
Quarters > 2 > cash Flow > net Change In Cash
-2692355
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.0427207488675978
Quarters > 2 > ratios > PB
0.036894321527208715
Quarters > 2 > ratios > ROE
-64.11745761968834
Quarters > 2 > ratios > ROA
-30.49572287392334
Quarters > 2 > ratios > FCF
-4608282
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
12982430434
Quarters > 3 > income Statement > cost Of Revenue
160302
Quarters > 3 > income Statement > gross Profit
-160302
Quarters > 3 > income Statement > operating Expenses
6048187
Quarters > 3 > income Statement > operating Income
-6208489
Quarters > 3 > income Statement > interest Expense
99000
Quarters > 3 > income Statement > pretax Income
-6131979
Quarters > 3 > income Statement > net Income
-6131979
Quarters > 3 > income Statement > eps
-1.8023008512461842
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3402306
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5971677
Quarters > 3 > income Statement > operating Margin
-0.04782223969204132
Quarters > 3 > income Statement > total Other Income Expense Net
76510
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
12211321
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
26325
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
12660803
Quarters > 3 > balance Sheet > property Plant Equipment
2203686
Quarters > 3 > balance Sheet > total Assets
14864489
Quarters > 3 > balance Sheet > payables
1270280
Quarters > 3 > balance Sheet > short Term Debt
2662200
Quarters > 3 > balance Sheet > long Term Debt
2436879
Quarters > 3 > balance Sheet > total Liabilities
7408984
Quarters > 3 > balance Sheet > equity
7455505
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-6131979
Quarters > 3 > cash Flow > depreciation
160302
Quarters > 3 > cash Flow > change In Working Capital
1831798
Quarters > 3 > cash Flow > cash From Operations
-4079530
Quarters > 3 > cash Flow > capital Expenditures
198462
Quarters > 3 > cash Flow > cash From Investing
-198462
Quarters > 3 > cash Flow > cash From Financing
6449164
Quarters > 3 > cash Flow > net Change In Cash
2171172
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.8023008512461842
Quarters > 3 > ratios > PB
0.02738088969157689
Quarters > 3 > ratios > ROE
-82.24766799834484
Quarters > 3 > ratios > ROA
-41.25253818008813
Quarters > 3 > ratios > FCF
-4277992
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.0003295216578858966
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
653090
Annuals > 0 > income Statement > gross Profit
-653090
Annuals > 0 > income Statement > operating Expenses
14991883
Annuals > 0 > income Statement > operating Income
-15644973
Annuals > 0 > income Statement > interest Expense
99000
Annuals > 0 > income Statement > pretax Income
-15545737
Annuals > 0 > income Statement > net Income
-15545737
Annuals > 0 > income Statement > eps
-4.078112682788242
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3811993
Annuals > 0 > income Statement > income Tax Expense
-263
Annuals > 0 > income Statement > EBITDA
-14892643
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
99236
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
12211321
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
26325
Annuals > 0 > balance Sheet > inventories
-54865
Annuals > 0 > balance Sheet > total Current Assets
12660803
Annuals > 0 > balance Sheet > property Plant Equipment
2203686
Annuals > 0 > balance Sheet > total Assets
14864489
Annuals > 0 > balance Sheet > payables
1270280
Annuals > 0 > balance Sheet > short Term Debt
2662200
Annuals > 0 > balance Sheet > long Term Debt
2436879
Annuals > 0 > balance Sheet > total Liabilities
7408984
Annuals > 0 > balance Sheet > equity
7455505
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-15545737
Annuals > 0 > cash Flow > depreciation
653090
Annuals > 0 > cash Flow > change In Working Capital
-4554224
Annuals > 0 > cash Flow > cash From Operations
-18451387
Annuals > 0 > cash Flow > capital Expenditures
211800
Annuals > 0 > cash Flow > cash From Investing
-211800
Annuals > 0 > cash Flow > cash From Financing
30822092
Annuals > 0 > cash Flow > net Change In Cash
12158905
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.078112682788242
Annuals > 0 > ratios > PB
0.02796806079534518
Annuals > 0 > ratios > ROE
-208.51353462978025
Annuals > 0 > ratios > ROA
-104.58305697558792
Annuals > 0 > ratios > FCF
-18663187
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
582918
Annuals > 1 > income Statement > gross Profit
-582918
Annuals > 1 > income Statement > operating Expenses
22176271
Annuals > 1 > income Statement > operating Income
-22759190
Annuals > 1 > income Statement > interest Expense
776000
Annuals > 1 > income Statement > pretax Income
-23534947
Annuals > 1 > income Statement > net Income
-23534947
Annuals > 1 > income Statement > eps
-10.399658425576103
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2263050
Annuals > 1 > income Statement > income Tax Expense
2
Annuals > 1 > income Statement > EBITDA
-22952031
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-775757
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
52416
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
14622
Annuals > 1 > balance Sheet > inventories
-14622
Annuals > 1 > balance Sheet > total Current Assets
578594
Annuals > 1 > balance Sheet > property Plant Equipment
2912842
Annuals > 1 > balance Sheet > total Assets
3491436
Annuals > 1 > balance Sheet > payables
5199105
Annuals > 1 > balance Sheet > short Term Debt
3375142
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10360865
Annuals > 1 > balance Sheet > equity
-6869429
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-23534947
Annuals > 1 > cash Flow > depreciation
582918
Annuals > 1 > cash Flow > change In Working Capital
7104816
Annuals > 1 > cash Flow > cash From Operations
-15034543
Annuals > 1 > cash Flow > capital Expenditures
224096
Annuals > 1 > cash Flow > cash From Investing
-224096
Annuals > 1 > cash Flow > cash From Financing
9954779
Annuals > 1 > cash Flow > net Change In Cash
-5303860
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-10.399658425576103
Annuals > 1 > ratios > PB
-0.018020251028142222
Annuals > 1 > ratios > ROE
342.60412328302687
Annuals > 1 > ratios > ROA
-674.0764258603051
Annuals > 1 > ratios > FCF
-15258639
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
621993
Annuals > 2 > income Statement > gross Profit
-621993
Annuals > 2 > income Statement > operating Expenses
17501718
Annuals > 2 > income Statement > operating Income
-17501718
Annuals > 2 > income Statement > interest Expense
174000
Annuals > 2 > income Statement > pretax Income
-17676232
Annuals > 2 > income Statement > net Income
-17850232
Annuals > 2 > income Statement > eps
-12.626962635994511
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1413660
Annuals > 2 > income Statement > income Tax Expense
174000
Annuals > 2 > income Statement > EBITDA
-17107707
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-174514
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5356276
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
234432
Annuals > 2 > balance Sheet > inventories
100339
Annuals > 2 > balance Sheet > total Current Assets
7869652
Annuals > 2 > balance Sheet > property Plant Equipment
3535405
Annuals > 2 > balance Sheet > total Assets
11405057
Annuals > 2 > balance Sheet > payables
762357
Annuals > 2 > balance Sheet > short Term Debt
5355808
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7523035
Annuals > 2 > balance Sheet > equity
3882022
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-17676232
Annuals > 2 > cash Flow > depreciation
394011
Annuals > 2 > cash Flow > change In Working Capital
598617
Annuals > 2 > cash Flow > cash From Operations
-15882808
Annuals > 2 > cash Flow > capital Expenditures
153420
Annuals > 2 > cash Flow > cash From Investing
-152652
Annuals > 2 > cash Flow > cash From Financing
4898991
Annuals > 2 > cash Flow > net Change In Cash
-11136469
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-12.626962635994511
Annuals > 2 > ratios > PB
0.019919310606688986
Annuals > 2 > ratios > ROE
-459.81789902272584
Annuals > 2 > ratios > ROA
-156.51155447973647
Annuals > 2 > ratios > FCF
-16036228
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
808441
Annuals > 3 > income Statement > gross Profit
-808441
Annuals > 3 > income Statement > operating Expenses
19870957
Annuals > 3 > income Statement > operating Income
-20679398
Annuals > 3 > income Statement > interest Expense
33407
Annuals > 3 > income Statement > pretax Income
-20709991
Annuals > 3 > income Statement > net Income
-20740493
Annuals > 3 > income Statement > eps
-14.671486071615522
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1413660
Annuals > 3 > income Statement > income Tax Expense
30502
Annuals > 3 > income Statement > EBITDA
-19868147
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-30593
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
16492745
Annuals > 3 > balance Sheet > short Term Investments
933
Annuals > 3 > balance Sheet > receivables
690248
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
18882279
Annuals > 3 > balance Sheet > property Plant Equipment
4003978
Annuals > 3 > balance Sheet > total Assets
22886257
Annuals > 3 > balance Sheet > payables
264687
Annuals > 3 > balance Sheet > short Term Debt
325787
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2042715
Annuals > 3 > balance Sheet > equity
20843542
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-20709991
Annuals > 3 > cash Flow > depreciation
708317
Annuals > 3 > cash Flow > change In Working Capital
-3213021
Annuals > 3 > cash Flow > cash From Operations
-10432772
Annuals > 3 > cash Flow > capital Expenditures
814736
Annuals > 3 > cash Flow > cash From Investing
-814736
Annuals > 3 > cash Flow > cash From Financing
26542581
Annuals > 3 > cash Flow > net Change In Cash
15295073
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-14.671486071615522
Annuals > 3 > ratios > PB
0.0037098877916238995
Annuals > 3 > ratios > ROE
-99.50560706045066
Annuals > 3 > ratios > ROA
-90.6242248350178
Annuals > 3 > ratios > FCF
-11247508
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.3516449201153482
Valuation > metrics > PB
0.09381169167276489
Valuation > final Score
70
Valuation > verdict
90.6% Undervalued
Profitability > metrics > ROE
-211.33349416153334
Profitability > metrics > ROA
-98.75899162015307
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.028164318824442
Risk > metrics > Interest Coverage
-0.010462876358064978
Risk > final Score
18
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.7358895671853256
Liquidity > metrics > Quick Ratio
1.7358895671853256
Liquidity > final Score
93
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
30
Prev Risks > 1
30
Prev Risks > 2
-203
Prev Liquidities > 0
91
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:36:10.931Z
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFundamentals Check: What dividend growth rate does ZAPPW offer - Weekly Trend Report & Expert Curated Trade Setup Alerts baoquankhu1.vn
Read more →Gains Recap: Will CINGW benefit from sector rotation - Quarterly Risk Review & Safe Entry Point Alerts baoquankhu1.vn
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Cingulate Inc. Warrants
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.